U.S. FDA issues warning letter to Zydus Lifesciences’ Baddi formulation unit

The U.S. Food and Drug Administration (U.S. FDA) has issued a warning letter to Zydus Lifesciences relating to the company’s formulation manufacturing facility in Baddi, Himachal Pradesh.

Raccontata dathehindu.com